As in AML cells, the blockade of Tim-3 inhibited the proliferation and cell growth of MDS cells (Figure 3C), suggesting that Tim-3 may contribute to tumor progression in MDS. This evidence concerns the gene HAVCR2 and acute myeloid leukemia.